Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 64 for “"Paroxetine"”.
-
A short total synthesis of (±)-paroxetine and a formal asymmetric synthesis of (–)-paroxetine
Paroxetine, a selective serotonin reuptake inhibitor, is a potent drug used for the treatment of depression for more than 20 years. Although numerous syntheses have been reported for this molecule, the manufacturing process still uses a resolution step, as it remains the shortest way to access …
-
Role of paroxetine in inflammatory cytokine responses in macrophages
… use of small molecules to modulate inflammation. Paroxetine, an FDA-approved selective serotonin (5HT) re-uptake inhibitor (SSRI) used as an anti-depressant, selectively inhibits GRK2 in cardiomyocytes. Previously, GRK2 was demonstrated to modulate lipopolysaccharide (LPS)-induced inflammatory …
-
The Influence of Psychotherapy and Depression on Platelet Imipramine and Paroxetine Binding
[<sup>3</sup>H]-Paroxetine and [<sup>3</sup>H]-imipramine are known to label with high affinity, a site which is associated with the serotonergic transporter in brain and platelets. [<sup>3</sup>H]-imipramine binding to platelet membranes appears to be a biological marker in depression, the …
-
Paroxetine and Oxytocin Regulation of Social Approach/Avoidance Response After Defeat Conditioning
… (Microtus ochrogaster) to study the effects of paroxetine and oxytocin (Oxt) treatment on behaviors and neuroendocrine systems sensitive to defeat conditioning. In this research, we exposed male and female voles to repeated SD conditioning and studied the behavioral, hormonal, and neurochemical …
-
An investigation of the mechanism of action of paroxetine in chronic myeloid leukaemia
Abstract not currently available.
-
Magnitude of placebo response in clinical trials of paroxetine for vasomotor symptoms : a meta-analysis.
… an alternative to hormone replacement therapy, paroxetine mesylate became the only nonhormonal treatment approved by the U.S. Food and Drug Administration, despite limited evidence for its efficacy. This meta-analysis aims to determine the magnitude of placebo response across all clinical trials …
-
Effects of chronic paroxetine and fluoxetine treatment on markers of suicidal behavior in adolescent rats
… selective serotonin reuptake inhibitor (SSRI) paroxetine, is not clinically effective in pediatric populations. There are many variables that increase the risk of suicide including genetic, social, psychological, and biological factors, making the evaluation of the effect of SSRIs on suicidal …
-
Effects of chronic paroxetine and fluoxetine treatment on markers of suicidal behavior in adolescent rats
… selective serotonin reuptake inhibitor (SSRI) paroxetine, is not clinically effective in pediatric populations. There are many variables that increase the risk of suicide including genetic, social, psychological, and biological factors, making the evaluation of the effect of SSRIs on suicidal …
-
Pharmacokinetics and pharmacodynamics of the selective serotonin reuptake inhibitors, fluoxetine and paroxetine, during pregnancy and the nursing period
… studies, the pharmacokinetics of fluoxetine and paroxetine were examined and compared in humans and sheep. In order to characterize drug disposition, several sensitive analytical methods for quantitative determination of fluoxetine and norfluoxetine isomers and paroxetine were developed using …
-
Enones and enals as latent enolates in catalytic C-C bond forming processes : total synthesis of (-)-paroxetine (Paxil®)
… synthesis of the blockbuster antidepressant (-)-paroxetine (PAXIL®). In transition metal catalysis, we have used enantioselective Cu-catalyzed conjugate addition of Grignard reagents to enones to provide magnesium enolates, which can be arylated using bismuth(V) reagents to furnish products of …
-
Enones and enals as latent enolates in catalytic C-C bond forming processes: total synthesis of (-)-paroxetine (Paxil®)
… synthesis of the blockbuster antidepressant (-)-paroxetine (PAXIL®). In transition metal catalysis, we have used enantioselective Cu-catalyzed conjugate addition of Grignard reagents to enones to provide magnesium enolates, which can be arylated using bismuth(V) reagents to furnish products of …
-
Adverse events during antidepressant treatment : prescription event monitoring studies with mirtazapine and paroxetine in general medical practice in England
… with the selective serotonin reuptake inhibitor paroxetine. Incidence densities (IDs) for reported events were calculated, during the first month of treatment (ID<sub>1</sub>) and during months two to six (ID<sub>2</sub>) for mirtazapine and paroxetine, The profile of reported adverse events was …
-
Investigation of the behavioural and neurobiological effects of SSRI discontinuation in mice
… from 12 days of treatment with the SSRI paroxetine, mice exhibited increased anxiety-like behaviour and behavioural inhibition on the elevated plus maze compared to saline-treated and continued paroxetine controls. These effects were short-lasting, having dissipated five days after …
-
ANTICHOLINERGIC BURDEN AND RISK OF COGNITIVE IMPAIRMENT IN OLDER ADULTS
… of MCP1 and IL-6 in Normal Human Astrocytes and Paroxetine on the production of MCP1 in Normal Human Astrocytes and Normal Human Brain Microvascular Endothelial Cells. Normal Human Astrocytes were cultured (seeded at 5,000 cells/cm2) and treated with a clinically relevant concentration …
-
Efeitos da paroxetina durante sessões de teste e reteste no labirinto em cruz elevado
… the effects of the systemic administration of paroxetine, a selective serotonin reuptake inhibition widely used to treat anxiety disorders, during a test (first exposure) and a retest (second exposure) session in the EPM taking place in consecutive days. Given that anxiety disorders exhibit …
-
Development and use of "stress" animal models of depression to study the mode of action of antidepressant drug treatments
… restraint stress with the administration of paroxetine (10 mg/kg p. o.), a selective serotonin reuptake inhibitor (SSRI), on the hypothalamic-pituitary-adrenocortical (HPA) axis were studied in adult male Wistar rats. Three weeks of restraint stress induced a 700% increase in plasma CORT and …
-
Antidepressant activated biochemical pathways and biomarker candidates
… drug treatment. DBA/2 mice were treated with paroxetine as a representative Selective Serotonin Reuptake Inhibitor (SSRI). Hippocampal protein levels were compared between chronic paroxetine- and vehicle-treated animals using in vivo 15N metabolic labeling combined with mass spectrometry. I …
-
Direct Effects of Selective Serotonin Reuptake Inhibitors, Fluoxetine, Sertraline and Paroxetine, and Atypical Antipsychotics, Aripiprazole and Clozapine, on Islet Beta Cell Mass and Function
… antidepressants, fluoxetine, sertraline and paroxetine, and atypical antipsychotic drugs (AAPs), aripiprazole and clozapine. <br/><br/>SSRIs block serotonin reuptake by inhibiting the serotonin reuptake transporter (SERT). SERT mRNA was detected by standard polymerase chain reaction (PCR) …
Page 1 of 4